Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

Others

Items 71-80 of 93

Page
per page
  1. Verteporfin
    A8327 Verteporfin
    Target: YAP
    Summary: Photosensitizer used in photodynamic therapy
      insoluble in EtOH; insoluble in H2O; ≥18.3 mg/mL
  2. Allopurinol
    A8360 Allopurinol
    Target: Xanthine oxidoreductases
    Summary: Xanthine oxidase inhibitor
      insoluble in H2O; insoluble in EtOH; ≥5.15 mg/mL
  3. Bexarotene
    A8380 Bexarotene
    Target: Retinoid X receptors (RXR)
    Summary: Retinoid Receptor agonist
      insoluble in H2O; ≥10.35 mg/mL
  4. Potassium Canrenoate
    A8506 Potassium Canrenoate
    Target: Aldosterone receptor
    Summary: Aldosterone antagonist
      insoluble in EtOH; insoluble in DMSO; ≥117.4 mg/mL
  5. Terfenadine
    A8534 Terfenadine
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: Histamine H1-receptor antagonist
      insoluble in H2O; ≥18 mg/mL
  6. Thioridazine HCl
    A8537 Thioridazine HCl
    Target: Cytochrome P450 (CYP450)|D1 and D5 Receptors|D2 Receptors|D3 Receptors|D4 Receptors
    Summary: Calcium channel protein inhibitor
  7. Tretinoin (Aberela)
    A8539 Tretinoin (Aberela)
    Target: RAR/RXR
    Summary: retinoic acid, treats acne vulgaris and keratosis pilaris
      insoluble in H2O; ≥11.9 mg/mL
  8. Chlorothiazide
    A8397 Chlorothiazide
    Target: Carbonic Anhydrases
    Summary: Carbonic anhydrase inhibitor
      insoluble in H2O; insoluble in EtOH; ≥14.85 mg/mL
  9. Vorapaxar
    A8809 Vorapaxar
    Target: Protease-Activated Receptors
    Summary: PAR-1 antagonist,potent and orally active
      ≥24.65 mg/mL
  10. NH125
    A8814 NH125
     1 Citation
    Target: eEF-2
    Summary: Selective eEF-2 kinase inhibitor
      ≥25.9 mg/mL

Items 71-80 of 93

Page
per page
Relate Categories
Now Shopping by
  1. Specificity Selective Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Category
  1. Actin1 item
  2. Adenylate cyclase1 item
  3. ATP citrate lyase 1 item
  4. Calmodulin protein kinase II1 item
  5. CaM kinase II5item
  6. Cytokine1 item
  7. DHODH1 item
  8. FBPase1 item
  9. FXR2item
  10. Glycoprotein1 item
  11. GSNOR1 item
  12. GSTP1-11 item
  13. Guanylyl Cyclase1 item
  14. Hydroxylases1 item
  15. IMPDH1 item
  16. Inositol Phosphatases2item
  17. LXR2item
  18. MDR multidrug resistance1 item
  19. NAE2item
  20. NADPH Oxidase1 item
  21. Nampt1 item
  22. Nuclear Receptors3item
  23. Oxygenases/Oxidases1 item
  24. PDHK1 item
  25. RAR/RXR5item
  26. RARs3item
  27. Reagents3item
  28. Renin1 item
  29. Retinoid X Receptors1 item
  30. Squalene epoxidase2item
  31. SGK1 item
  32. SPHK1 item
  33. Synthases/Synthetases1 item
  34. Thymidine phosphorylase1 item
  35. Transcription Factors1 item
  36. β(1,3)-D-Glucan Synthase1 item
  37. XAO1 item
  38. Others37item
  39. Renal Diseases1 item
Reversibility
  1. Reversible1 item
Target
  1. Glycoproteins1 item
  2. AP-11 item
  3. MMP2item
  4. Thymidine Phosphorylases1 item
  5. Voltage-gated Potassium (KV) Channels1 item
  6. Farnesoid X receptors (FXRs)1 item
  7. P-glycoprotein (P-gp)1 item
  8. SGK1 item
  9. Liver X receptors (LXRs)2item
  10. Neuraminidases (NA)1 item
  11. RARs7item
  12. ATP Citrate Lyases1 item
  13. Microtubules/Tubulins1 item
  14. Inositol Phosphatases1 item
  15. FAK1 item
  16. AMPK1 item
  17. Gutathione S-transferase1 item
  18. PDHK1 item
  19. S-nitrosoglutathione reductase1 item
  20. Cytochrome P450 (CYP450)1 item
  21. Renin1 item
  22. Actin1 item
  23. BMI-11 item
  24. Ca2 /calmodulin-dependent protein kinases (CaMKs)5item
  25. MLK31 item
  26. Protease-Activated Receptors1 item
  27. Calcium chelator1 item
  28. Sphingosine kinases (SphKs)1 item
  29. BCPCF efflux1 item
  30. D1 and D5 Receptors1 item
  31. D2 Receptors1 item
  32. D3 Receptors1 item
  33. Angiotensin-Converting Enzymes (ACEs)1 item
  34. ROS and Other Gaseous Donors1 item
  35. C5a receptors1 item
  36. YAP1 item
  37. Squalene epoxidases2item
  38. Nampt1 item
  39. eIF4F1 item
  40. P2X Receptors1 item
  41. Glutaminases1 item
  42. Carbonic Anhydrases2item
  43. BLM1 item
  44. NADPH Oxidases2item
  45. Synthases/Synthetases2item
  46. Histamine H1 Receptors1 item
  47. RAR/RXR1 item
  48. Ionophores1 item
  49. Xanthine oxidoreductases1 item
  50. Dihydroorotate dehydrogenase1 item
  51. Guanylyl Cyclases1 item
  52. MNK1 item
  53. eEF-21 item
  54. Inward Rectifier Potassium (Kir) Channels1 item
  55. calcium chelator1 item
  56. Nuclear Receptors1 item
  57. fibrinolysis1 item
  58. D4 Receptors1 item
  59. Aldosterone receptor1 item
  60. NAE2item
  61. Ubiquitin-activating Enzyme E11 item
  62. SUMOylation1 item
  63. ATGL1 item
  64. Adenylyl Cyclases1 item
  65. Retinoic acid-related Orphan Receptors (RORs)1 item
  66. Rev-Erb Receptors1 item
  67. Retinoid X receptors (RXR)1 item
  68. SHIP1 item
  69. FXR1 item
Related Disease
  1. Abscesses And Esophageal Candidiasis1 item
  2. Acute Disseminated Candidiasis1 item
  3. Acute Myeloid Leukemia2item
  4. Bladder Cancer1 item
  5. Brain Injuries Studies1 item
  6. Breast Cancer6item
  7. Cancer31item
  8. Candida Peritonitis1 item
  9. Candidemia1 item
  10. Colon Cancer5item
  11. Colorectal Cancer4item
  12. Dyslipidemia1 item
  13. Fungal Infection1 item
  14. Glioblastoma2item
  15. Hepatocellular Carcinoma1 item
  16. HIV2item
  17. Inflammatory Diseases4item
  18. Leukemia1 item
  19. Lung Cancer3item
  20. Lymphoma5item
  21. Melanoma1 item
  22. Non-small Cell Lung Cancer2item
  23. Ovarian Cancer2item
  24. Pancreatic Cancer1 item
  25. Psoriasis1 item
  26. Rheumatoid Arthritis1 item
  27. Schizophrenia1 item
  28. Squamous Cell Carcinoma1 item
  29. Type 2 Diabetes3item